JP2023532444A5 - - Google Patents

Info

Publication number
JP2023532444A5
JP2023532444A5 JP2022579814A JP2022579814A JP2023532444A5 JP 2023532444 A5 JP2023532444 A5 JP 2023532444A5 JP 2022579814 A JP2022579814 A JP 2022579814A JP 2022579814 A JP2022579814 A JP 2022579814A JP 2023532444 A5 JP2023532444 A5 JP 2023532444A5
Authority
JP
Japan
Prior art keywords
hla
methylation
infection
subject
classifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022579814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532444A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/038763 external-priority patent/WO2021262894A1/en
Publication of JP2023532444A publication Critical patent/JP2023532444A/ja
Publication of JP2023532444A5 publication Critical patent/JP2023532444A5/ja
Pending legal-status Critical Current

Links

JP2022579814A 2020-06-23 2021-06-23 呼吸器病原体を診断し、covid-19に関連する転帰を予測する方法 Pending JP2023532444A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063042669P 2020-06-23 2020-06-23
US63/042,669 2020-06-23
PCT/US2021/038763 WO2021262894A1 (en) 2020-06-23 2021-06-23 Methods for diagnosing respiratory pathogens and predicting covid-19 related outcomes

Publications (2)

Publication Number Publication Date
JP2023532444A JP2023532444A (ja) 2023-07-28
JP2023532444A5 true JP2023532444A5 (enExample) 2024-07-03

Family

ID=79281779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022579814A Pending JP2023532444A (ja) 2020-06-23 2021-06-23 呼吸器病原体を診断し、covid-19に関連する転帰を予測する方法

Country Status (10)

Country Link
US (1) US20240093318A1 (enExample)
EP (1) EP4168593A4 (enExample)
JP (1) JP2023532444A (enExample)
KR (1) KR20230038486A (enExample)
CN (1) CN116096920A (enExample)
AU (1) AU2021297245A1 (enExample)
BR (1) BR112022026509A2 (enExample)
CA (1) CA3184128A1 (enExample)
MX (1) MX2023000105A (enExample)
WO (1) WO2021262894A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4308017A4 (en) * 2021-03-18 2025-02-12 The Board of Trustees of the Leland Stanford Junior University Systems and methods to generate a surgical risk score and uses thereof
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
WO2024008955A1 (en) * 2022-07-08 2024-01-11 Age Labs As Method of screening for severe covid-19 susceptibility
EP4484575A1 (de) * 2023-06-30 2025-01-01 Cerascreen GmbH Markersequenzen zur diagnose und therapiesteuerung von patienten mit testosteron-defizienz

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US8114414B2 (en) 1994-11-08 2012-02-14 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of cervical cancer
EP2298900A1 (en) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for treating intracellular diseases
US6099848A (en) 1997-11-18 2000-08-08 The Trustees Of The University Of Pennsylvania Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
GB9726555D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine
WO2001041782A2 (en) 1999-12-09 2001-06-14 Chiron Corporation Method for administering a cytokine to the central nervous system and the lymphatic system
US6855320B2 (en) 2000-03-29 2005-02-15 The Trustees Of The University Of Pennsylvania Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
AU2001255196A1 (en) 2000-03-29 2001-10-08 The Trustees Of The University Of Pennsylvania Compositions and methods for enhancing immunogenicity of antigens
WO2002002807A2 (en) * 2000-06-30 2002-01-10 Epigenomics Ag Diagnosis of diseases associated with cell signalling
US8771702B2 (en) 2001-03-26 2014-07-08 The Trustees Of The University Of Pennsylvania Non-hemolytic LLO fusion proteins and methods of utilizing same
US7794728B2 (en) 2002-05-29 2010-09-14 The Regents Of The University Of California Attenuated Listeria spp. and methods for using the same
US8337861B2 (en) 2003-01-09 2012-12-25 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
KR101192652B1 (ko) 2003-02-06 2012-10-19 앤저 테라퓨틱스 인코퍼레이티드 비포식 세포로의 침투가 약화된 리스테리아, 리스테리아를 포함하는 백신, 및 그것의 사용방법
US7935804B2 (en) 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
US7665238B2 (en) 2006-04-03 2010-02-23 S.C. Johnson & Son, Inc. Air freshener with holder
CN101755044B (zh) 2007-05-18 2014-06-11 米迪缪尼有限公司 通过冻干泡沫保存生物活性材料
JP5985397B2 (ja) 2009-11-11 2016-09-06 アドバクシス インコーポレイテッド 組換えリステリア株およびそれを含む免疫原性組成物
EP2521797A4 (en) * 2010-01-04 2013-07-10 Lineagen Inc DNA METHYLATION BIOMARKER FOR LUNG FUNCTION
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
SG10201700916SA (en) 2012-12-27 2017-03-30 Aduro Biotech Inc Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
CA2955612C (en) 2014-07-18 2022-05-17 Advaxis, Inc. Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
EP3169355A4 (en) 2014-07-18 2018-07-25 Advaxis, Inc. Listeria-based immunogenic compositions for eliciting anti-tumor responses
MA41218A (fr) 2014-12-19 2017-10-24 Advaxis Inc Combinaison de vaccin à base de listeria comportant des anticorps anti-ox40 ou anti-gitr
BR112019018272A2 (pt) * 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer
MA47821A (fr) * 2017-03-10 2020-01-15 Self Screen Bv Classificateur de méthylation pour la détection de cancers invasifs induits par le hpv, de cancers gynécologiques et anogénitaux non induits par le hpv et de leurs lésions précurseurs de haut grade

Similar Documents

Publication Publication Date Title
JP2023532444A5 (enExample)
Farias et al. Toll-like receptors, IFN-γ and IL-12 expression in bovine leukemia virus-infected animals with low or high proviral load
Miyazaki et al. Corneal endothelial cells activate innate and acquired arm of anti-viral responses after cytomegalovirus infection
Gil et al. Expression at mRNA level of cytokines and A238L gene in porcine blood-derived macrophages infected in vitro with African swine fever virus (ASFV) isolates of different virulence
Zhou et al. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection
AU2001270631B2 (en) Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
Woolsey et al. A highly attenuated panfilovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and 3 species of Ebola virus
Isa et al. Differential expression of immune-related genes in the bursa of Fabricius of two inbred chicken lines following infection with very virulent infectious bursal disease virus
JP2023537229A5 (enExample)
Zheng et al. RNA sequencing analyses of gene expressions in a canine macrophages cell line DH82 infected with canine distemper virus
Soha et al. HLA class II DRB1, DQA1, DQB1 loci in patients with HIV infection and tuberculosis in a Latvian cohort group
Miyazaki et al. Herpes simplex virus type 1–induced transcriptional networks of corneal endothelial cells indicate antigen presentation function
Yadav et al. Detection of human herpesvirus 7 in salivary glands
Inoshima et al. Spatial and temporal genetic homogeneity of orf viruses infecting Japanese serows (Capricornis crispus)
Chihab et al. IFNL4 rs12979860 polymorphism influences HBV DNA viral loads but not the outcome of HBV infection in Moroccan patients
Satoh et al. Enteroviraf RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy
JP2024539370A5 (enExample)
Uchiumi The putative implications of duplicated GGAA-motifs located in the human interferon regulated genes (ISGs)
Almukhtar et al. Genetic polymorphism of IFNA1 and IFNAR1 genes in Covid-19 Iraqi patients
Taskin et al. Infectivity and replication inhibition effect of 5-fluorouracil on herpes simplex virus type-1 associated with mutations in thymidine kinase gene
Motamedifar et al. Symptomatic reactivation of HSV infection correlates with decreased serum levels of TNF-α
Chen Supplementary Figure
Kadyrova et al. ANALYSIS OF THE DYNAMICS OF GENE EXPRESSION IN PATIENTS WITH ACUTE COVID-19 AND IN RECOVERY PERIOD
Omae et al. Genetics of infectious diseases
Aubaid et al. A surveillance of varicella zoster virus among school age children in Al-Diwaniyah governorate